当前位置:首页 - 行情中心 - 海森药业(001367) - 财务分析 - 资产负债表

海森药业

(001367)

  

流通市值:25.00亿  总市值:31.32亿
流通股本:1.22亿   总股本:1.52亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金468,150,357.11799,779,879.12909,485,294.67518,939,993.7
  交易性金融资产620,000,000270,000,000151,695,000490,000,000
  应收票据及应收账款77,403,348.5367,660,938.2389,914,598.7165,883,676.23
  其中:应收票据3,477,9206,610,795.093,618,047.925,159,125
        应收账款73,925,428.5361,050,143.1486,296,550.7960,724,551.23
  应收款项融资22,202,954.5127,575,831.1913,462,588.454,856,786.87
  预付款项4,168,326.777,373,939.82,450,111.176,588,637.21
  其他应收款合计99,566.92148,361.2125,276.04110,653.24
  存货107,245,867.61108,189,256.96108,469,100.91125,693,095.41
  其他流动资产963,282.871,022,624.915,223,963.0512,919,439.85
  流动资产合计1,300,233,704.321,281,750,831.411,280,825,9331,224,992,282.51
非流动资产:
  投资性房地产3,427,692.523,499,508.833,571,325.143,643,141.45
  固定资产190,138,745.63191,355,799.2196,199,594.19183,877,281.87
  在建工程44,608,291.9330,547,286.2921,357,661.2329,660,474.41
  使用权资产6,846,582.87,252,137.87,417,692.87,793,607.38
  无形资产116,500,739.19117,249,472.92117,816,187.98117,588,590.03
  长期待摊费用239,083.06148,501.24208,952.15243,582.98
  其他非流动资产694,872.69763,543.832,843,826.22717,395.84
  非流动资产合计362,456,007.82350,816,250.11349,415,239.71343,524,073.96
  资产总计1,662,689,712.141,632,567,081.521,630,241,172.711,568,516,356.47
流动负债:
  应付票据及应付账款36,298,103.9226,806,703.7344,882,769.4847,244,913.39
  其中:应付票据--9,476,00016,051,000
        应付账款36,298,103.9226,806,703.7335,406,769.4831,193,913.39
  合同负债3,553,803.774,457,504.643,851,317.196,131,834.88
  应付职工薪酬13,597,250.7710,357,617.9618,482,649.4113,936,035.7
  应交税费11,630,495.4512,940,046.115,898,821.3111,597,169.11
  其他应付款合计29,999,442.3628,757,022.1429,864,254.8633,743,925.43
  一年内到期的非流动负债1,354,1121,341,728.41,327,936.011,315,162.52
  其他流动负债661,240.022,798,800.841,988,104.134,875,282.43
  流动负债合计97,094,448.2987,459,423.81116,295,852.39118,844,323.46
非流动负债:
  租赁负债6,139,807.876,164,740.326,101,829.587,277,145.44
  递延收益4,254,420.294,521,268.044,788,115.794,606,963.54
  递延所得税负债7,431,430.498,567,208.339,293,463.625,618,893.24
  非流动负债合计17,825,658.6519,253,216.6920,183,408.9917,503,002.22
  负债合计114,920,106.94106,712,640.5136,479,261.38136,347,325.68
所有者权益(或股东权益):
  实收资本(或股本)152,351,200152,351,200152,351,200152,351,200
  资本公积740,365,670.99737,718,496.94734,834,532.14731,130,785.62
  减:库存股18,859,396.818,859,396.818,859,396.829,045,176.8
  专项储备1,795,266.441,681,443.961,381,323.361,348,017.83
  盈余公积68,691,164.3768,691,164.3768,691,164.3754,410,850.18
  未分配利润603,425,700.2584,271,532.55555,363,088.26521,973,353.96
  归属于母公司股东权益合计1,547,769,605.21,525,854,441.021,493,761,911.331,432,169,030.79
  股东权益合计1,547,769,605.21,525,854,441.021,493,761,911.331,432,169,030.79
  负债和股东权益合计1,662,689,712.141,632,567,081.521,630,241,172.711,568,516,356.47
公告日期2026-08-212026-04-282026-03-262025-10-22
审计意见(境内)标准无保留意见
TOP↑